Debiopharm S.A. Release: 2006 Mauvernay Research Excellence Award

LAUSANNE, Switzerland, November 20 /PRNewswire/ -- The Debiopharm Group (Debiopharm), a global independent biopharmaceutical development company specialising in oncology and serious medical conditions, today honored Dr Frank E. Jones, Associate Professor of Biochemistry and program member at the Tulane Cancer Center, with the 2006 Mauvernay Research Excellence Award for his outstanding achievements in the field of advanced metastatic breast cancer.

MORE ON THIS TOPIC